We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Says Interim Analysis Will Assess Higher Number of Cases than Anticipated
Moderna Says Interim Analysis Will Assess Higher Number of Cases than Anticipated
Moderna announced last week that it has seen an increased rate of COVID-19 cases across sites in its late-stage vaccine trial and, as a result, its first interim analysis will include significantly more coronavirus cases than anticipated.